E Itzhak Lerner

This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2005-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: E Itzhak Lerner. Retrieved from https://idiyas.com/inventor/e-itzhak-lerner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 18.2

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 274(Granted Patents)

Company Filing History:

11 out of 505

Teva Pharmaceutical Industries Limited

patents

Years Active: 2005-2016

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9375403 - Formulations of 6-mercaptopurine (2016-06-28),

2. 9180097 - Formulations of 6-mercaptopurine (2015-11-10),

3. 9107832 - Risperidone microparticles formed by sublimation (2015-08-18),

4. 8663703 - Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them (2014-03-04),

5. 8653060 - Formulations of 6-mercaptopurine (2014-02-18),

6. 8188067 - Formulations of 6-mercaptopurine (2012-05-29),

7. 7674480 - Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition (2010-03-09),

8. 7611722 - Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it (2009-11-03),

9. 7579333 - Therapy using a combination of raloxifene and alendronate (2009-08-25),

10. 7195778 - Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery (2007-03-27),

11. 6881420 - Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation (2005-04-19),

Title: E Itzhak Lerner: Innovator in Pharmaceutical Formulations

Introduction

E Itzhak Lerner is a prominent inventor based in Petach Tikva, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. With a total of 11 patents to his name, Lerner's work has had a substantial impact on drug delivery and bioavailability.

Latest Patents

Among his latest innovations are improved formulations of 6-mercaptopurine. These formulations exhibit better bioavailability and faster dissolution compared to previous versions. This advancement is crucial for enhancing the effectiveness of treatments that utilize this medication.

Career Highlights

Lerner is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on developing innovative solutions that address critical healthcare needs. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.

Collaborations

Throughout his career, Lerner has collaborated with notable colleagues, including Moshe Flashner-Barak and Vered Rosenberger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

E Itzhak Lerner's contributions to pharmaceutical formulations demonstrate his commitment to improving drug efficacy and patient outcomes. His innovative work continues to influence the field and pave the way for future advancements in medication development.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: